ticlopidine has been researched along with Extravascular Hemolysis in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gremmel, T | 1 |
| Fedrizzi, S | 1 |
| Weigel, G | 1 |
| Eichelberger, B | 1 |
| Panzer, S | 1 |
| Katoh, M | 1 |
| Karasawa, T | 1 |
| Doi, H | 1 |
| Odawara, A | 1 |
2 other studies available for ticlopidine and Extravascular Hemolysis
| Article | Year |
|---|---|
Underlying mechanism and specific prevention of hemolysis-induced platelet activation.
Topics: Adenosine Diphosphate; Adult; Aged; Apyrase; Blood Group Incompatibility; Blood Platelets; Clopidogr | 2017 |
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemoly | 2001 |